➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Johnson and Johnson
McKinsey
Baxter
Mallinckrodt

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,387,612

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,387,612 protect, and when does it expire?

Patent 8,387,612 protects ADASUVE and is included in one NDA.

This patent has twenty-one patent family members in six countries.

Summary for Patent: 8,387,612
Title:Self-contained heating unit and drug-supply unit employing same
Abstract: Heating units, drug supply units and drug delivery articles capable of rapid heating are disclosed. Heating units comprising a substrate and a solid fuel capable of undergoing an exothermic metal oxidation reaction disposed within the substrate are disclosed. These heating units can be actuated by electrical resistance, by optical ignition or by percussion. Drug supply units and drug delivery articles wherein a solid fuel is configured to heat a substrate to a temperature sufficient to rapidly thermally vaporize a drug disposed thereon are also disclosed.
Inventor(s): Damani; Ramesh (Sunnyvale, CA), Hale; Ron L. (Sandia Park, NM), Myers; Daniel J. (Mountain View, CA), Quintana; Reynaldo J. (Redwood City, CA), Solas; Dennis W. (San Francisco, CA), Song; Soonho (Hillsborough, CA), Soni; Pravin (Sunnyvale, CA), Tom; Curtis (San Mateo, CA), Sharma; Kirshnamohan (Milpitas, CA)
Assignee: Alexza Pharmaceuticals, Inc. (Mountain View, CA)
Application Number:12/485,704
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,387,612
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,387,612

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alexza Pharms ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Medtronic
AstraZeneca
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.